- Abstract Number: 0195
JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s Disease
- Abstract Number: 0029
JAK1 Regulates Autophagy and Reinforces the Inflammatory and Autoimmune Potentials in Rheumatoid Arthritis Synovial Fibroblasts
- Abstract Number: 0773
Janus Kinase (JAK) Inhibition with Baricitinib: Dosing and Patient-Reported Outcomes in Refractory Juvenile Dermatomyositis
- Abstract Number: 0259
JIA Diagnoses and Trends from 2006-2019: Has the U.S. ICD-9-to-ICD-10 Transition Created Coding Artifacts?
- Abstract Number: 0008
Jo-1-Binding and Clonally-Expanded Memory B Cells Express Germline and Somatically-Mutated B Cell Receptors in Anti-tRNA Synthetase Syndrome Patients
- Abstract Number: 0264
Joint Acoustic Emissions as a Biomarker to Differentiate Between Active and Inactive Juvenile Idiopathic Arthritis via 2-stage Machine Learning Classifier
- Abstract Number: 1510
Joint CD8+ Tissue Resident Memory Cell Activation Produces Local Inflammatory Arthritis
- Abstract Number: 0726
Joint Safety of Tanezumab versus NSAIDs; A Combined Assessment of Benefit and Harm
- Abstract Number: 1018
Joint-Draining Popliteal Lymphatic Vessels Exhibit Lymphatic Muscle Cell Dysfunction in TNF-Tg Mice with Inflammatory Arthritis
- Abstract Number: 1349
Joint-specific Responses to Tofacitinib and Adalimumab in Patients with Psoriatic Arthritis: Post Hoc Analysis of a Phase 3 Study
ACR Convergence 2021
November 5-9, 2021. All Virtual.